Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorproethazine is a drug of the phenothiazine group, structurally related to other phenothiazines such as chlorpromazine. It has been described as a muscle relaxant or tranquilizer and has been marketed in Europe, primarily as a topical cream for the treatment of muscle pain. Its primary use is for symptomatic relief of muscle pain rather than psychiatric indications. Chlorproethazine acts centrally and peripherally, consistent with other phenothiazines, but its detailed mechanism of action is not fully elucidated; it likely involves antagonism at dopamine receptors and possibly other neurotransmitter systems. The drug has also been associated with photoallergic contact dermatitis when used topically[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorproethazine.